PI3KCA Mutations in Uterine Cervix Carcinoma.
Ioannis A VoutsadakisPublished in: Journal of clinical medicine (2021)
Frequent mutations of PIK3CA gene in squamous cervical carcinomas may represent an opportunity for targeted therapies development both inhibiting the PI3K kinase and associated pathway defects. Increased TMB may additionally confer immunotherapy sensitivity.